Comparison between apalutamide and enzalutamide in patients with metastatic castration-sensitive prostate cancer
Latest Information Update: 31 Mar 2022
At a glance
- Drugs Apalutamide (Primary) ; Enzalutamide
- Indications Prostate cancer
- Focus Therapeutic Use
- 31 Mar 2022 New trial record
- 19 Feb 2022 Results presented at the 2022 Genitourinary Cancers Symposium